IGC Pharma (IGC) Free Cash Flow Growth (3y) (2013 - 2025)
IGC Pharma (IGC) Free Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-18.24% |
| Jun 30, 2025 |
15.23% |
| Mar 31, 2025 |
8.33% |
| Dec 31, 2024 |
18.13% |
| Sep 30, 2024 |
23.99% |
| Jun 30, 2024 |
2.71% |
| Mar 31, 2024 |
40.70% |
| Dec 31, 2023 |
6.07% |
| Sep 30, 2023 |
15.57% |
| Jun 30, 2023 |
32.93% |
| Mar 31, 2023 |
17.46% |
| Dec 31, 2022 |
16.76% |
| Sep 30, 2022 |
19.40% |
| Jun 30, 2022 |
16.88% |
| Mar 31, 2022 |
5.65% |
| Dec 31, 2021 |
-22.42% |
| Sep 30, 2021 |
-94.75% |
| Jun 30, 2021 |
-53.45% |
| Mar 31, 2021 |
-33.80% |
| Dec 31, 2020 |
-79.03% |
